Orforglipron (Foundayo) expands oral treatment options for weight management
1. Orforglipron (Foundayo) introduces a new oral glucagon-like peptide-1 (GLP-1) receptor agonist that can be taken without food or timing...
Pharma
Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders
1. Glucagon-like peptide-1 (GLP-1) receptor agonists are associated with a lower risk of developing new substance use disorders. 2. These...
Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric
1. Maternal use of benzodiazepines or non-benzodiazepine hypnotics (Z-hypnotics) during pregnancy was not associated with an increased risk of psychiatric...
Sparsentan (Filspari) becomes first approved treatment for focal segmental glomerulosclerosis
1. Sparsentan (Filspari) becomes the first approved treatment specifically for focal segmental glomerulosclerosis. 2. Clinical trial data show meaningful reductions...
New targeted therapy daraxonrasib improves survival in pancreatic cancer
1. Daraxonrasib significantly improves survival in metastatic pancreatic cancer compared with standard chemotherapy. 2. Strong response rates in combination therapy...
Global medicine supply chains face mounting pressure amid Strait of Hormuz disruptions
1. Shipping slowdowns in the Strait of Hormuz are disrupting the movement of key pharmaceutical ingredients and finished generic drugs....
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options
Geopolitical instability in the Strait of Hormuz threatens global generic drug supply Ongoing escalations in the Strait of Hormuz have...
COVID-19 vaccination is associated with reduced risk of new-onset atrial fibrillation following COVID-19 infection
1. COVID-19 vaccination was associated with a reduced 24-month risk of new-onset atrial fibrillation/flutter after COVID-19 infection. Evidence Rating Level:...
Tenecteplase (TNKase) may worsen functional outcomes in older patients with minor ischemic stroke
1. Tenecteplase (TNKase) improved early recanalization and short-term neurologic recovery, but in patients older than 80 years with minor ischemic...
The Scan by 2 Minute Medicine®: TikTok “Fibermaxxing” trend targets gut microbiome diversity, Jennifer Aniston’s “Strength for 50+” ritual spotlights photobiomodulation, American Lung Association issues respiratory warning over viral “mouth taping” fad, and Psychiatric Times highlights initiative to close the schizophrenia mortality gap
The Scan by 2 Minute Medicine® is a pharmaceutical and biotech newsletter and exclusive benefit for 2 Minute Medicine Plus...
